SciTransfer
Organization

MYCRONIC AB

Swedish precision lithography company applying advanced patterning and thin-film manufacturing to bioprinting, stretchable electronics, and soft robotics research.

Large industrial companydigitalSENo active H2020 projects
H2020 projects
3
As coordinator
0
Total EC funding
€1.3M
Unique partners
18
What they do

Their core work

Mycronic is a Swedish precision technology company specializing in advanced lithography and pattern generation systems for electronics manufacturing. In H2020 projects, they contribute their deep expertise in high-resolution patterning, thin-film deposition, and precision manufacturing to interdisciplinary research — from light-sheet lithography for bioprinting to stretchable electronics and soft robotics actuators. Their industrial role is providing the precision equipment and process know-how that turns laboratory concepts into manufacturable systems.

Core expertise

What they specialise in

Precision lithography and pattern generationprimary
2 projects

Central to BRIGHTER (light-sheet lithography for bioprinting) and SOMIRO (thin film fabrication for soft actuators).

Stretchable and flexible electronics manufacturingsecondary
1 project

SINTEC project focused on stretchable PCBs, rigid-stretch integration, and skin-conformable electronics.

Bioprinting and biofabricationemerging
1 project

BRIGHTER project applied lithography expertise to bioprinting complex tissues — their largest H2020 investment at EUR 945,960.

Soft robotics and micro-actuatorsemerging
1 project

SOMIRO project involved dielectric actuators, nano-MOS structures, and thin film solar cells for milli-scale soft robots.

Evolution & trajectory

How they've shifted over time

Early focus
Stretchable electronics for healthcare
Recent focus
Biofabrication and soft robotics

Mycronic's H2020 trajectory shows a consistent thread of precision manufacturing applied to increasingly unconventional domains. Their earliest projects (2019) focused on wearable electronics — stretchable PCBs and smart patches for healthcare monitoring. By 2021, they moved into soft robotics and bioprinting, applying their lithography core competency to biological and micro-mechanical systems far from traditional electronics manufacturing.

Mycronic is extending its precision manufacturing platform into life sciences and micro-robotics — expect continued interest in projects where high-resolution patterning meets biological or soft-matter systems.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European8 countries collaborated

Mycronic exclusively participates as a consortium partner, never as coordinator, which is typical for large industrial companies contributing specialized equipment and process expertise to research-driven projects. With 18 unique partners across 8 countries in just 3 projects, they engage in moderately large consortia and do not appear to repeat partners, suggesting they are open to new collaborations rather than locked into fixed networks. Their role is that of a technology enabler — bringing industrial manufacturing capability to academic-led research.

Mycronic has collaborated with 18 distinct partners across 8 European countries through 3 RIA projects, indicating a broad but not deep consortium network. Their partner diversity suggests they are sought out for specific technical contributions rather than building long-term consortium alliances.

Why partner with them

What sets them apart

Mycronic bridges the gap between industrial-scale precision manufacturing and frontier research domains like bioprinting and soft robotics. Few companies bring production-grade lithography and patterning expertise to EU research consortia — most partners in these fields are universities or research institutes. For consortium builders, Mycronic offers a credible pathway from laboratory proof-of-concept to industrially viable manufacturing processes.

Notable projects

Highlights from their portfolio

  • BRIGHTER
    Their largest H2020 investment (EUR 945,960), applying industrial lithography to bioprinting — an unusual cross-domain transfer from electronics to life sciences.
  • SOMIRO
    Demonstrates expansion into soft robotics with thin film solar cells and dielectric actuators, signaling new application areas for their precision manufacturing capabilities.
Cross-sector capabilities
Health and biomedical engineeringAdvanced manufacturing and Industry 4.0Robotics and autonomous systemsWearable electronics and IoT
Analysis note: Profile based on only 3 H2020 projects (2019-2024), all as participant. Mycronic is a well-established industrial company whose full capability portfolio extends well beyond what these EU projects reveal. The cross-domain pattern (electronics → bioprinting → soft robotics) is clear but the small project count limits confidence in identifying their primary EU research strategy versus opportunistic participation.